REAL WORLD DATA IN LYMPHOMA AND SURVIVAL IN ADULTS

Status: Recruiting
Location: See all (37) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

REALYSA cohort is a population-based epidemiological platform in real-life for lymphomas designed to enrich prognostic data, by integrating together epidemiological, clinical and biological data. REALYSA is a platform perfectly set up to * Study prognostic factors using integrated epidemiological and biological data (genetics), to better characterize the determinants of refractoriness and relapse in patients with lymphoma, to follow the growing number of survivors and describe median to long-term sequela, second cancer, quality of life (QoL)… * Document treatment effectiveness in real life and observance * Address socio-economical questions

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Signature of the consent form for participation in the REALYSA cohort

• Aged over 18 at the time of inclusion

• Diagnosed with lymphoma in the last 6 months (180 days)

• Lymphoma subtype belonging to at least one of the 7 histological subtypes: diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, T-cell lymphoma, Hodgkin's lymphoma, Burkitt lymphoma

Locations
Other Locations
France
Unité d'Hématologie Clinique, CH D'ARRAS
RECRUITING
Arras
Service d'Hématologie, CHU Jean Minjoz
RECRUITING
Besançon
Institut Bergonié
RECRUITING
Bordeaux
Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine
RECRUITING
Bordeaux
Centre Hospitalier Pierre Oudot
RECRUITING
Bourgoin
Service d'Hématologie, Institut d'Hématologie de Basse Normandie
RECRUITING
Caen
METROPOLE SAVOIE - SITE CHAMBERY, place Lucien Biset,
RECRUITING
Chambéry
Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Estaing, CHU de Clermont-Ferrand
RECRUITING
Clermont-ferrand
Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor
RECRUITING
Créteil
CHU Francois MITTERRAND
RECRUITING
Dijon
Service Hématologie, Centre Hospitalier de Dunkerque
RECRUITING
Dunkirk
Service Oncologie médicale, Groupe Hospitalier Mutualiste de Grenoble, Institut Daniel Hollard,
RECRUITING
Grenoble
CHD Vendée
RECRUITING
La Roche-sur-yon
Service d'Hématologie Clinique, Centre Hospitalier Universitaire Michallon
RECRUITING
La Tronche
Clinique Victor Hugo
RECRUITING
Le Mans
Centre hospitalier Libourne
RECRUITING
Libourne
Service des maladies du sang, Hôpital Claude Huriez, CHRU de Lille
RECRUITING
Lille
Service Oncologie médicale, HOPITAL SAINT VINCENT-DE-PAUL
RECRUITING
Lille
Service Hématologie Clinique et Thérapie Cellulaire, CHU DE LIMOGES - HOPITAL DUPUYTREN,
RECRUITING
Limoges
Département d'Hématologie et Oncologie, Centre Léon Bérard
RECRUITING
Lyon
Département d'Hématologie Clinique, Hôpital Saint-Eloi,
RECRUITING
Montpellier
Service Hématologie, GH REGION MULHOUSE ET SUD ALSACE - HOPITAL EMILE MULLER,
RECRUITING
Mulhouse
Service d'Hématologie clinique, Centre Hospitalier Universitaire de Nantes
RECRUITING
Nantes
Centre Hospitalier de Niort
RECRUITING
Niort
Service Hématologie, Hôpital St Louis
RECRUITING
Paris
CHU Haut-Lévêque
RECRUITING
Pessac
Centre Hospitalier Lyon Sud
RECRUITING
Pierre-bénite
Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire de Poitiers
RECRUITING
Poitiers
Hématologie Clinique, CHU PONTCHAILLOU
RECRUITING
Rennes
Service Hématologie, Centre Hospitalier de Roubaix - Hôpital Victor Provo
RECRUITING
Roubaix
Service Hématologie, UNIVERSITE DE ROUEN, CENTRE HENRI BECQUEREL
RECRUITING
Rouen
Service Hématologie, CH YVES LE FOLL
RECRUITING
Saint-brieuc
Service Hématologie, Institut Curie - Hôpital René HUGUENIN
RECRUITING
Saint-cloud
Département d'Hématologie Clinique et Thérapie Cellulaire, Institut de Cancérologie Lucien Neuwirth
RECRUITING
Saint-priest-en-jarez
Hôpitaux Universitaires de Strasbourg
RECRUITING
Strasbourg
Institut Universitaire du Cancer
RECRUITING
Toulouse
Hématologie Clinique, CH DE BRETAGNE ATLANTIQUE
RECRUITING
Vannes
Contact Information
Primary
Hervé Ghesquières, MD
herve.ghesquieres@chu-lyon.fr
04 78 86 43 40
Backup
Alain Monnereau, MD
A.Monnereau@bordeaux.unicancer.fr
05 56 33 33 33
Time Frame
Start Date: 2018-11-14
Estimated Completion Date: 2027-11-14
Participants
Target number of participants: 6000
Treatments
All enrolled patients
All patient who signed the consent form for participation to the study
Sponsors
Collaborators: The Lymphoma Academic Research Organisation
Leads: Hospices Civils de Lyon

This content was sourced from clinicaltrials.gov